Clinical Trials Logo

Genital Neoplasms, Female clinical trials

View clinical trials related to Genital Neoplasms, Female.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT01356329 Suspended - Clinical trials for Malignant Female Reproductive System Neoplasm

Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients

Lovenox
Start date: October 2009
Phase: Phase 3
Study type: Interventional

Prophylactic treatment will start from surgery until the patients are discharged from the hospital(18). Then each patient will have 2 follow up visit in gyne- oncology clinic. The first visit will be 2 weeks from discharge & the second visit will be 3 months after surgery. In each visit patient will be evaluated for any evidence of thrombo-embolic events clinically & radiologically if needed ( spiral CT, V/Q scan & lower limp Doppler ). Any side effect or adverse reaction will be reported & it will be evaluated if it is related to the drug used or not.